dronabinol has been researched along with Acute Myelogenous Leukemia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akmut, F; Illing, B; Kampa-Schittenhelm, KM; Kanz, L; Salih, HR; Salitzky, O; Schittenhelm, MM | 1 |
Chubb, CB; Gemmell, MA; Huberman, E; Maeda, S; Murison, G | 1 |
3 other study(ies) available for dronabinol and Acute Myelogenous Leukemia
Article | Year |
---|---|
Dronabinol has preferential antileukemic activity in acute lymphoblastic and myeloid leukemia with lymphoid differentiation patterns.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Dronabinol; Gene Expression Regulation, Leukemic; Gene Knockdown Techniques; Humans; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2016 |
Letter: Tetrahydrocannabinol and chemotherapy.
Topics: Adult; Bone Neoplasms; Cannabis; Dronabinol; Female; Humans; Hyperalgesia; Hyperesthesia; Leukemia, Myeloid, Acute; Male; Pain; Phytotherapy; Vomiting | 1976 |
Cannabinoids induce incomplete maturation of cultured human leukemia cells.
Topics: Calcitriol; Cannabidiol; Cannabinoids; Cannabinol; Cell Differentiation; Cells, Cultured; Dronabinol; Humans; Leukemia, Myeloid, Acute; Lymphocyte Activation; Monocytes; Tetradecanoylphorbol Acetate | 1987 |